A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
Also Known As:
Alphagan; 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate; 5-bromo-6-(imidazolidinylideneamino)quinoxaline; 5-bromo-6-(imidazolin-2-ylamino)quinoxaline; AGN 190342; AGN-190342; Alphagan P; Brimonidine; Brimonidine Purite; Brimonidine Tartrate (1:1); Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer; Brimonidine Tartrate, (R-(R*,R*))-Isomer; Bromoxidine; Mirvaso; Ratio-Brimonidine; Sanrosa; UK 14,304; UK 14,304-18; UK 14304; UK 14308; UK-14,304-18; UK-14,308; UK-14304; AGN190342; Ratio Brimonidine; UK 14,304 18; UK 14,30418; UK 14,308; UK14,30418; UK14,308; UK14304; 6-quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)